Institute of Human Virology Annual Meeting 2016-2021

项目摘要 人类病毒学研究所年度国际会议在国家癌症研究所开始 在20世纪70年代中期，汇集了世界上最重要的艾滋病毒/艾滋病生物学专家，特别是 基础科学和疫苗科学以及新的治疗和预防方法。这五个具体目标 会议是为了传播选定的计划主题内最新的研究成果;批判性地 评估新发现对未来研究方向的影响;提供一个论坛， 发现、支持和培养下一代艾滋病研究人员; 妇女、少数民族/种族和其他历来在科学领域代表性不足的个人的参与。 2013年，会议移至俄罗斯联邦莫斯科，与莫斯科中心共同主办 艾滋病的治疗和预防。这一重大的地点变化认识到病毒的重要性， 在俄罗斯联邦、欧洲和亚洲，艾滋病毒/艾滋病等疾病的防治工作取得了进展，并开辟了新的途径， 在基础研究、诊断、预防和治疗人类病毒性疾病方面的合作， 地理中心。该活动于2014年回到巴尔的摩，发扬了深入科学的传统 在新发现的前沿，并在2015年提供了关于病毒潜伏机制和最近的会议 在了解艾滋病治愈的障碍方面取得了进展。去年的会议还包括一次特别会议， 全球病毒威胁：将基础科学转化为公共卫生实践，同时还继续关注 结构生物学、免疫学和疫苗，以及关于艾滋病毒合并感染/合并症的讨论， 扩展到包括丙型肝炎和癌症。会议通常由以下人员组织： 不同的观点和不同种族的参与者，并穿插有专门的讲座， 在讨论中引入新的学科。会议成果与更广泛的科学界分享 通过在会议材料和网上公布所有发言者和海报摘要。2016年，第十八届 年度国际会议定于9月19日至22日在马里兰州的巴尔的摩举行，有400人参加 预计，包括重大NIH代表。专题会议将包括： 临床病毒学;免疫学和免疫发病机制;病毒结构和生物学; HIV治疗 研究;疫苗学进展;淋巴瘤和癌症中的感染因子;以及全球更新。 在为期4天的会议期间将张贴海报，晚上的活动旨在吸引 参与者与合作者，建立新的科学伙伴关系，并培养下一代艾滋病毒/艾滋病 青年研究人员在讲台上介绍了选定的摘要。作为传统，A 奖学金计划将为妇女、少数族裔和其他典型的代表性不足的群体提供 有机会以很少或没有成本参与。

PROJECT SUMMARY The Annual International Meeting of the Institute of Human Virology began at the National Cancer Institute in the mid-1970s and brings together the world's foremost experts on the biology of HIV/AIDS, particularly on basic and vaccine science and new treatment and prevention approaches. The five specific aims of this conference are to disseminate the most current research findings within the selected program topics; critically assess the impact of new findings on future directions for research; provide a forum for discussion of current and emerging issues; identify, support, and build the next generation AIDS researcher; and increase participation by women, ethnic/racial minorities, and other individuals traditionally underrepresented in science. In 2013, the meeting was moved to Moscow, Russian Federation and co-sponsored with the Moscow Center for HIV Treatment and Prevention. This significant change of venue recognized the importance of viral diseases, including HIV/AIDS, in the Russian Federation, Europe, and Asia, and opened up new avenues of collaboration in basic research, diagnosis, prevention, and treatment of human viral diseases among these geographic centers. The event returned to Baltimore in 2014 carrying forth the tradition of in-depth science at the cutting edge of new discovery, and in 2015 offered sessions on mechanisms of viral latency and recent advances in understanding the barriers to an HIV cure. Last year's meeting also included a special session on global virus threats: translating basic science to public health practice, while focus also continued on structural biology, immunology, and vaccines, and discussions on HIV co-infections/co-morbidities were expanded to included hepatitis C as well as cancer. Meeting sessions are customarily organized with divergent perspectives and ethnically diverse participants and are interspersed with special lectures designed to introduce new disciplines to discussions. Conference results are shared with the broader scientific community through publication of all speaker and poster abstracts in meeting materials and online. In 2016, the 18th Annual International Meeting is scheduled for Sep 19-22 in Baltimore, MD, with 400 participants anticipated, including significant NIH representation. Thematic sessions will include: Advances in Clinical Virology; Immunology and Immunopathogenesis; Viral Structure and Biology; HIV Cure Research; Progress in Vaccinology; Infectious Agents in Lymphoma and Cancer; and a Global Update. Posters will be displayed throughout the 4-day meeting, with evening activities designed to engage participants with collaborators, build new scientific partnerships, and foster the next generation of HIV/AIDS researcher with podium presentation of selected abstracts by young investigators. As is the tradition, a scholarship initiative will offer women, minorities, and other typically under-represented populations with the opportunity to participate for very little or no cost.